Daligdig, Baby Girl .

HRN: 28-79-37  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2026
AMPICILLIN 250MG (VIAL)
04/04/2026
04/10/2026
IV
120mg
Q12H
Possibly Septics Newborn (PROM X 2 Days)
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines